Accession |
PRJCA015540 |
Title |
SHR-3680-I/II-CRPC-TOL/PK/PD Phase I/II study of tolerance, pharmacokinetics, and efficacy of SHR3680 in patients with advanced castration-resistant prostate cancer |
Relevance |
Medical |
Data types |
clinical information,metabolome data,etc
|
Organisms |
Homo sapiens
|
Description |
PK detects the metabolic data generated,etc. |
Sample scope |
Multiisolate |
Release date |
2023-03-14 |
Grants |
Agency |
program |
Grant ID |
Grant title |
NA
|
|
NA
|
|
|
Submitter |
luchongyang
chongyang
lu (chongyang.lu@hengrui.com)
|
Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
Submission date |
2023-03-14 |